HCW Biologics

Yahoo Finance • 2 days ago

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

MIRAMAR, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to... Full story

Yahoo Finance • 18 days ago

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment

Watch the "What This Means" video here Featuring the Company’s pembrolizumab-based immune checkpoint inhibitor MIRAMAR, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.... Full story

Yahoo Finance • 24 days ago

HCW Biologics to Participate in the 2025 Maxim Growth Summit

MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthsp... Full story

Yahoo Finance • 24 days ago

HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer

MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to exten... Full story

Yahoo Finance • last month

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program

Watch the "What This Means" video here Featuring Company’s second-generation T-Cell Engager program and advantages over first-generation Company’s T-Cell Engager program has made improvements in manufacturability, preclinical safety pr... Full story

Yahoo Finance • 2 months ago

HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing

Wugen closed a $115 million equity financing led by Fidelity Management & Research Company HCW Biologics holds a minority equity interest in Wugen MIRAMAR, Fla., Sept. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or... Full story

Yahoo Finance • 2 months ago

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid tumors Discovery of unique combination of cytokines in multi-functional fusion protein molecule t... Full story

Yahoo Finance • 2 months ago

Which stocks are experiencing notable movement on Friday?

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT GCTK [ht... Full story

Yahoo Finance • 2 months ago

Keep an eye on the top gainers and losers in Friday's session.

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GCTK [https://www.chartmill.... Full story

Yahoo Finance • 2 months ago

Which stocks are gapping on Friday?

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] GAP UP STOCKS TICKER CHANGE COMMENT OPI [https://w... Full story

Yahoo Finance • 2 months ago

Top movers in Friday's pre-market session

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT GCT... Full story

Yahoo Finance • 2 months ago

HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

HCW Biologics conducted investigative study to show safe dose levels of its lead drug candidate in non-human primates that were well tolerated at a level significantly higher than the identified efficacious dose level Program has addresse... Full story

Yahoo Finance • 2 months ago

Which stocks are experiencing notable movement on Monday?

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] GAINERS TICKER CHANGE COMMENT OSRH [https://www.chartmill.com/stock/quote/OSRH/profile] 103.0% With a... Full story

Yahoo Finance • 2 months ago

Let's take a look at the stocks that are in motion in today's session.

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 2 months ago

The market is filled with gapping stocks in Monday's session.

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT HCWB [https://www.chartmill.com/st... Full story

Yahoo Finance • 2 months ago

Which stocks are moving before the opening bell on Monday?

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT O... Full story

Yahoo Finance • 2 months ago

HCW Biologics reports promising results for new cancer immunotherapy

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ:HCWB), a small-cap biotech company with a market capitalization of $8.8 million, announced Monday that it has developed a second-generation pembrolizumab-based immunotherapy showing improved effec... Full story

Yahoo Finance • 2 months ago

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their infiltration into solid tumors Presentation at Nova Sou... Full story

Yahoo Finance • 3 months ago

HCW Biologics GAAP EPS of -$16.16, revenue of $180.4M

* HCW Biologics press release [https://seekingalpha.com/pr/20204127-hcw-biologics-reports-second-quarter-2025-business-highlights-and-financial-results] (NASDAQ:HCWB [https://seekingalpha.com/symbol/HCWB]): Q2 GAAP EPS of -$16.16. * Re... Full story

Yahoo Finance • 3 months ago

HCW Biologics GAAP EPS of -$16.16

* HCW Biologics press release [https://seekingalpha.com/pr/20204127-hcw-biologics-reports-second-quarter-2025-business-highlights-and-financial-results] (NASDAQ:HCWB [https://seekingalpha.com/symbol/HCWB]): Q2 GAAP EPS of -$16.16. * Re... Full story